Tag: Revive Therapeutics - Page 6 - Psychedelic Alpha

Read more about the article Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

Post published:July 31, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Announces Submission of Investigational New Drug Application (IND) with U.S. FDA for Phase 3 Confirmatory Study for Bucillamine in COVID-19

Revive Therapeutics Announces Submission of Investigational New Drug Application (IND) with U.S. FDA for Phase 3 Confirmatory Study for Bucillamine in COVID-19

Post published:June 30, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Expands Research Partnership for Novel Formulation Development and Clinical Research of Psilocybin with the University of Wisconsin-Madison

Revive Therapeutics Expands Research Partnership for Novel Formulation Development and Clinical Research of Psilocybin with the University of Wisconsin-Madison

Post published:June 12, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Provides Update on Discussions with Health Canada in Pre-CTA Meeting

Revive Therapeutics Provides Update on Discussions with Health Canada in Pre-CTA Meeting

Post published:June 9, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Announces Filing of a Pre-CTA Meeting Request with Health Canada and Update on U.S. FDA IND Filing and Phase 3 Clinical Trial Design for Bucillamine in the Treatment of COVID-19

Revive Therapeutics Announces Filing of a Pre-CTA Meeting Request with Health Canada and Update on U.S. FDA IND Filing and Phase 3 Clinical Trial Design for Bucillamine in the Treatment of COVID-19

Post published:June 3, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Provides Corporate Update on its Pharmaceutical Initiatives

Revive Therapeutics Provides Corporate Update on its Pharmaceutical Initiatives

Post published:May 13, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program

Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program

Post published:April 29, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.